SUBSCRIBE
IQVIA Blog Digest
For all the latest industry insights, please subscribe to the IQVIA U.S. blog digest.
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREBlog
Focus on Patient Outcomes via Clinical Nurse Educators
Per-diem model is efficient, cost effective
Feb 03, 2021
Most people around the world are looking forward to changes following the COVID-19 crisis; nearly three-fourths of those surveyed in 28 countries do not want their daily lives to return to pre-pandemic norms1. It seems they view the health crisis as a disruptive influence – beyond its terrible death toll and economic and social impact.
Indeed, many conveniences borne of necessity during the pandemic (such as working from home, grocery deliveries, and digital health visits) have found favor with consumers and will likely continue to some extent post pandemic. In-home visits from clinical nurse educators, also called “nurse ambassadors,” is yet another service that’s come to the forefront during the pandemic and is an amenity that’s not likely to recede even when the virus does.
Patients’ feedback on such support has been overwhelmingly positive. One patient wrote: “This treatment has literally given me my life back and working with the nurse educator made me feel like I truly had someone to turn to with any questions, and they took care of everything. Thank you for this ground-breaking treatment and your dedication to patients dealing with their physically and emotionally debilitating disease.”
When patient education is needed most
- Indication is new
- Therapy/device is novel
- Dosing/self-administration is complex
- Treatment regimen is long-term and overwhelming
- Adverse events are expected
- REMS programs are underway
- Value must be demonstrated
- Patients have comorbidities
- Behavioral changes are required
- Patient discontinuation is high
A patient-centric commercial model
Deploying nurse educators is a way to align your resources with your goal of improving patient outcomes, rather than merely increasing share of voice. IQVIA’s nurse educators are highly experienced and well-trained professionals who visit patients face-to-face. Because of this, they tend to have instant credibility with their patients as they intrinsically understand the patient journey. Successful programs are able to
- Identify and address patients’ knowledge gaps
- Bolster the patient’s motivation to initiate therapy and continue treatment regimens
- Foster positive health behavior
IQVIA’s nurses are drawn from a national network of 2,200 clinical professionals who have all been carefully selected and trained so that they can be deployed in as little as two weeks.
Per-diem engagement
Life sciences companies can also now engage nurse educators on a per-diem basis rather than having to maintain a dedicated staff with fixed costs. This outsourcing approach allows you to “pay for what you use.” The resources assigned to your program can be scaled up or down as needed and can be secured as one component in a comprehensive patient support program or as a stand-alone service.
Outsourcing the nurse educator role doesn’t mean giving up all control; first, you can request nurses who are best suited to the assignment based on several criteria, including demographics, licenses, certifications, training, experience, and work history. Second, you have transparency into the team’s productivity and activities with customized dashboards that measure everything from expenses to impact by nurse and region.
The clinical nurse resources you need to support patient adherence and improve patient health outcomes are now available nearly on-demand; you can contract who you need, when you need them without absorbing fixed costs. The model is a win-win for patients, manufacturers, and the broader healthcare system. To learn more, contact us.
1 Survey conducted by Ipsos, reported here
Overcoming barriers to treatment with a clinical network
Read the facts about deploying a remote phlebotomy service to help patients start — and stay — on therapies.